摘要
"看病贵、看病难"是近年来最为百姓关注的事件之一,其中药费虚高的问题尤为突出。政府对药价的管制药价却越来越高,这在现有的医疗体制下,医院为了自身的生存和发展,利用其在药品上的双向垄断地位——垄断买方和垄断卖方获得超额利润造成的。强化"第三方责任",可以改变医疗市场上的博弈形势,减少信息不对称,有效控制药品价格。为此,需要提高医疗保险覆盖率,加强新药审批管理,由市场力量促进企业集中,改革医生收入分配体制,完善医疗服务信息披露制度。
The problem of inadequate and overly expensive medical services is one of the hottest issues among the common people, and the phenomena of pharmaceutical price inflation is outstanding. Although the government has taken many steps to reduce the price of drugs through kinds of govemmental administration means, it is not completely effective. The cause of that is in the current medical system, for its survival and development, the hospital uses the two-directional monopoly on pharmaceutical retailing: seller's and buyer's monopoly to acquire excess profits. Strengthening third-party liability can change the game situation and reduce information asymmetry, so that pharmaceutical price can be controlled effectively. Therefore, the medical insurance coverage and execute stricter rules for approving new drugs need to be improved, enterprise concentration need to be promoted by market power, the doctors' income distribution system need to be reformed, and medi- cal service information disclosure system need to be improved.
出处
《中国卫生经济》
北大核心
2010年第7期47-50,共4页
Chinese Health Economics
关键词
第三方责任
双向垄断
以药养医
third-party liability
two-directional monopoly
maintaining medicine